Site Map

Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents. This site is intended for use by healthcare professionals of the United States and Puerto Rico. Janssen Pharmaceuticals, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.

Capitalized product names are trademarks of Janssen Pharmaceuticals, Inc. Third party trademarks are registered trademarks of their respective owners.

Legal Notice | Privacy Policy | Medical Information Center | Unsubscribe | Site Map Site Map

Last Updated 2017

You are here

INVOKANA® Site Map

IMPORTANT SAFETY INFORMATION for INVOKANA®

INVOKANA® (canagliflozin) HCP Central

A free helpful tool for you AND your patients